You can buy or sell Trevena and other stocks, options, ETFs, and crypto commission-free!
Trevena, Inc. Common Stock, also called Trevena, is a biopharmaceutical company, which focuses on the development and commercialization of innovative treatment options that target and treat diseases affecting the central nervous system, or CNS. Read More The company product pipeline consists of Olinvo, TRV250, and TRV734. Trevena was founded by Robert Joseph Lefkowitz, Scott DeWire, Howard A. Rockman, Jonathan Violin and Erin Whalen on November 9, 2007 and is headquartered in Chesterbrook, PA.
52 Week High
52 Week Low
Will Trevena Continue to Surge Higher?
As of late, it has definitely been a great time to be an investor in Trevena, Inc. TRVN. The stock has moved higher by 31.5% in the past month, while it is also above its 20 Day SMA too. This combination of strong price performance and favorable technical, could suggest that the stock may be on the right path. We certainly think that this might be the case, particularly if you consider TRVN’s recent earnings estimate revision activity. From this look, the company’s future is quite favorable; as TRVN has ea...
Yahoo FinanceMar 19
Watch These Four Healthcare Stocks Set The Pace On Tuesday
CORAL GABLES, FL/ ACCESSWIRE / March 19, 2019 / In the last few months, the healthcare stock market has responded favorably to the fact that the healthcare industry is one of the fastest changing sectors in the global marketplace.
-$0.08 per share
-$0.10 per share